title: Hyperacute post-thrombolysis hematoma by MRI.
authors.affiliation: University of Calgary, Calgary Stroke Program, 1403-29 Street NW, Calgary, Alberta T2N 2T9, CANADA. alexis.gagnon@calgaryhealthregion.ca
authors.forename: A J
authors.initials: AJ
authors.lastname: Gagnon
authors.forename: P A
authors.initials: PA
authors.lastname: Barber
mesh_terms: D000208:Acute Disease; D000368:Aged; D001037:Aphasia / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D002545:Brain Ischemia / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D002536:Cerebral Arteries / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D002540:Cerebral Cortex / Q000098:blood supply / Q000473:pathology* / Q000503:physiopathology; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D002544:Cerebral Infarction / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects; D006406:Hematoma / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D006429:Hemiplegia / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D010291:Paresis / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator